Document and Entity Information
Document and Entity Information - USD ($) | 12 Months Ended | ||
Dec. 31, 2016 | Mar. 28, 2017 | Jun. 30, 2016 | |
Document And Entity Information | |||
Entity Registrant Name | GLUCOSE HEALTH, INC. | ||
Entity Central Index Key | 1,420,108 | ||
Document Type | 10-K | ||
Document Period End Date | Dec. 31, 2016 | ||
Amendment Flag | false | ||
Current Fiscal Year End Date | --12-31 | ||
Is Entity a Well-known Seasoned Issuer | No | ||
Is Entity a Voluntary Filer? | No | ||
Is Entity's Reporting Status Current? | Yes | ||
Entity Filer Category | Smaller Reporting Company | ||
Entity Public Float | $ 78,485 | ||
Entity Common Stock, Shares Outstanding | 3,312,273 | ||
Document Fiscal Period Focus | FY | ||
Document Fiscal Year Focus | 2,016 |
BALANCE SHEETS
BALANCE SHEETS - USD ($) | Dec. 31, 2016 | Dec. 31, 2015 |
CURRENT ASSETS | ||
Cash | $ 20,542 | $ 2,055 |
Accounts receivable | 11,724 | 3,150 |
Inventory | 8,370 | |
Due from affiliate | 250 | |
Prepaid expenses | 639 | 1,282 |
Total current assets | 32,905 | 15,107 |
Other Asset | ||
Intellectual assets, net of accumulated amortization of $60 and $60, respectively | 240 | 300 |
TOTAL ASSETS | 33,145 | 15,407 |
CURRENT LIABILITIES | ||
Accounts payable and accrued expenses | 138,134 | 94,920 |
Notes payable | 38,631 | |
Convertible notes payable, related parties | 35,000 | |
Accrued interest | 5,000 | 6,075 |
Notes payable, related party | 112,157 | 100,829 |
Convertible notes payable | 164,670 | 201,402 |
Other notes payable | 35,000 | |
Total current liabilities | 528,592 | 403,226 |
TOTAL LIABILITIES | 528,592 | 403,226 |
COMMITMENTS AND CONTINGENCIES | ||
STOCKHOLDERS' DEFICIT | ||
Preferred stock, no par value, 1,000 shares authorized, 1,000 shares issued and outstanding as of December 31, 2016 and 2015 | 113,200 | 113,200 |
Common stock, $0.001 par value, 200,000,000 shares authorized, 3,312,273 and 2,451,888 shares issued and outstanding as of December 31, 2016 and 2015, respectively | 3,312 | 2,452 |
Additional paid in capital | 5,687,956 | 5,386,001 |
Stock subscription | 23,000 | 23,000 |
Accumulated other comprehensive loss | (75,278) | (75,278) |
Accumulated deficit | (6,247,637) | (5,837,194) |
Total stockholders' deficit | (495,447) | (387,819) |
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | $ 33,145 | $ 15,407 |
BALANCE SHEETS (Parenthetical)
BALANCE SHEETS (Parenthetical) - USD ($) | Dec. 31, 2016 | Dec. 31, 2015 |
Balance Sheets Parenthetical | ||
Net of accumulated amortization | $ 0 | $ 0 |
STOCKHOLDERS' DEFICIT | ||
Preferred stock, shares authorized | 1,000 | 1,000 |
Preferred stock, shares issued | 1,000 | 1,000 |
Preferred stock, shares outstanding | 1,000 | 1,000 |
Common stock, par value | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 200,000,000 | 200,000,000 |
Common stock, shares issued | 3,312,273 | 2,451,888 |
Common stock, shares outstanding | 3,312,273 | 2,451,888 |
STATEMENTS OF OPERATIONS
STATEMENTS OF OPERATIONS - USD ($) | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Statements Of Operations | ||
REVENUE | $ 313,229 | $ 4,272 |
COST OF REVENUES | ||
Cost of revenues | 294,062 | 3,875 |
GROSS PROFIT | 19,167 | 397 |
OPERATING EXPENSES | ||
Professional fees | 52,101 | 8,927 |
Stock based compensation | 1,875 | 32,775 |
Research and development | 48 | |
General and administrative | 51,838 | 114,820 |
Total operating expenses | 105,814 | 156,570 |
LOSS FROM OPERATIONS | (86,647) | (156,173) |
OTHER INCOME (EXPENSE) | ||
Interest income (expense) | (323,796) | (120,028) |
Loss on conversion of debt | (10,436) | |
Gain on forgiveness of accounts payable | 20,573 | |
Total other expense | (323,796) | (109,891) |
LOSS BEFORE INCOME TAXES | (410,443) | (266,064) |
PROVISION FOR (BENEFIT FROM) INCOME TAXES | ||
NET LOSS | $ (410,443) | $ (266,064) |
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING BASIC AND DILUTED (2) | 2,793,759 | 1,956,371 |
NET LOSS PER SHARE - BASIC AND DILUTED | $ (0.15) | $ (0.14) |
STATEMENT OF CHANGES IN STOCKHO
STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) | Preferred Stock | Common Stock | Additional Paid-In Capital | Stock To Be Issued | Accumulated Deficit | Accumulated Other Comprehensive Loss | Total | |||||||
Beginning balance, shares at Dec. 31, 2014 | [1] | 1,000 | 1,309,825 | |||||||||||
Beginning balance, amount at Dec. 31, 2014 | [1] | $ 113,200 | $ 1,310 | $ 5,228,346 | $ 23,000 | $ (5,571,130) | $ (75,278) | $ (280,552) | ||||||
Common stock issued in satisfaction of debt, shares | 961,196 | |||||||||||||
Common stock issued in satisfaction of debt, amount | $ 961 | 15,519 | 16,480 | |||||||||||
Common stock issued as compensation, shares | 70,867 | |||||||||||||
Common stock issued as compensation, amount | $ 71 | 5,929 | 6,000 | |||||||||||
Common stock issued for sevices, shares | 111,000 | |||||||||||||
Common stock issued for sevices, amount | $ 110 | 26,655 | 26,775 | |||||||||||
Discounts on shares issued for notes payable | 109,541 | 109,541 | ||||||||||||
Net loss for the year | (266,064) | (266,064) | ||||||||||||
Ending balance, shares at Dec. 31, 2015 | [1] | 1,000 | 2,451,888 | |||||||||||
Ending balance, amount at Dec. 31, 2015 | $ 113,200 | [1] | $ 2,452 | [1] | 5,386,001 | [1] | 23,000 | [1] | (5,837,194) | [1] | (75,278) | [1] | (387,819) | |
Common stock issued in satisfaction of debt, shares | 754,135 | |||||||||||||
Common stock issued in satisfaction of debt, amount | $ 754 | 4,814 | 5,568 | |||||||||||
Common stock issued for sevices, shares | 25,000 | |||||||||||||
Common stock issued for sevices, amount | $ 25 | 1,850 | 1,875 | |||||||||||
Discounts on shares issued for notes payable | 294,722 | 294,722 | ||||||||||||
Common stock issued for accrued interest, shares | 81,250 | |||||||||||||
Common stock issued for accrued interest, amount | $ 81 | 569 | 650 | |||||||||||
Net loss for the year | (410,443) | (410,443) | ||||||||||||
Ending balance, shares at Dec. 31, 2016 | [1] | 1,000 | 3,312,273 | |||||||||||
Ending balance, amount at Dec. 31, 2016 | $ 113,200 | [1] | $ 3,312 | [1] | $ 5,687,956 | [1] | $ 23,000 | [1] | $ (6,247,637) | [1] | $ (75,278) | [1] | $ (495,447) | |
[1] | (3) The common stock shares authorized, issued and outstanding have been adjusted to reflect a 10 to 1 reverse split, which was effective in February 2014 and 50 to 1 reverse split, which was effective in November 2014 |
STATEMENTS OF CASH FLOWS
STATEMENTS OF CASH FLOWS - USD ($) | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
OPERATING ACTIVITIES: | ||
Net loss | $ (410,443) | $ (266,064) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Common stock issued for services | 1,875 | 32,775 |
Amortization of note discount | 239,927 | 43,076 |
Amortization of intangible asset | 60 | |
Beneficial conversion feature of notes payable | 109,541 | |
Change in assets and liabilities | ||
Increase in accounts receivable | (8,574) | (4,572) |
Decrease (Increase) in inventory | 8,370 | (8,370) |
(Increase) Decrease in prepaid expenses and other current assets | 643 | 37,577 |
Increase (Decrease) in accounts payable and accrued expenses | 128,879 | (59,739) |
Total adjustments | 371,180 | 150,288 |
Net cash used in operating activities | (39,263) | (115,776) |
CASH FLOWS FROM INVESTING ACTIVITIES: | ||
Increase in due from affilliate | 250 | (250) |
Net cash used in investing activities | 250 | (250) |
CASH FLOWS FROM FINANCING ACTIVITIES: | ||
Proceeds from notes and loans payable | 128,500 | 113,210 |
Payments on notes and loans payable | (71,000) | |
Net cash provided by financing activities | 57,500 | 113,210 |
NET INCREASE (DECREASE) IN CASH | 18,487 | (2,816) |
CASH - BEGINNING OF YEAR | 2,055 | 4,871 |
CASH - END OF YEAR | 20,542 | 2,055 |
NON-CASH OPERATING AND INVESTING ACTIVITIES: | ||
Beneficial conversion feature | 294,722 | 109,541 |
Conversion of notes payable and accrued interest to common stock | 6,155 | 4,100 |
Conversion of liability to common stock | $ 4,315 |
ORGANIZATION AND BASIS OF PRESE
ORGANIZATION AND BASIS OF PRESENTATION | 12 Months Ended |
Dec. 31, 2016 | |
Notes to Financial Statements | |
NOTE 1 - ORGANIZATION AND BASIS OF PRESENTATION | We were incorporated under the laws of State of Nevada on March 27, 2007, as Bio-Solutions Corp. Our current authorized common shares are 200,000,000 and 1000 preferred voting shares. As of December 31, 2016, 3,312,273 of the Companys common stock and 1,000 shares of the Companys preferred stock were issued and outstanding. On October 30, 2014, we changed our name to Glucose Health, Inc. Our business is the manufacturing and distribution of Glucose Health® Daily Blood Sugar Maintenance. Glucose Health® is a dietary supplement in the form of a sweet tea mix formulated from nine natural ingredients shown in certain clinical research such as that published by the National Institutes of Health, National Library of Medicine website (see www.glucosehealth.com/clinical-trials), to have a beneficial impact upon blood glucose, triglyceride and cholesterol levels and regular digestive health. As of December 31, 2016, the Companys Glucose Health® Daily Blood Sugar Maintenance Blueberry Tea Mix (60-Day Supply) product is stocked in the "Diabetic Supplies" section of most Walmartpharmacies in all 50 states. Going Concern These financial statements have been prepared on a going concern basis, which implies the Company will continue to realize its assets and discharge its liabilities in the normal course of business. These financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The Company had a working capital deficiency of $495,687 and an accumulated deficit of $6,247,637 as of December 31, 2016. The continuation of the Company as a going concern is dependent upon the ability of the Company to obtain additional financing to continue operations. The Company estimates it will need $120,000 in additional capital to continue operations through the end of 2017. This additional capital may not be obtained on terms favorable to the Company, if at all. If the capital needed to continue operations cannot be obtained outside of the Company, the Companys officers/director may need to contribute capital to sustain operations. The Companys officers/director are not required to contribute capital. These factors raise substantial doubt regarding the ability of the Company to continue as a going concern. |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 12 Months Ended |
Dec. 31, 2016 | |
Notes to Financial Statements | |
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to revenue recognition, bad debts, investments, intangible assets, and income taxes. Our estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may differ from these estimates. Comprehensive Income (Loss) The Company adopted ASC 220-10, Reporting Comprehensive Income. ASC 220-10 requires the reporting of comprehensive income in addition to net income from operations.Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of information that historically has not been recognized in the calculation of net income. Cash Flow Reporting The Company follows ASC 230, Statement of Cash Flows, for cash flow reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (indirect method) as defined by ASC 230, Statement of Cash Flows, to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments. Cash and Cash Equivalents The Company considers all highly liquid debt instruments and other short-term investments with maturity of three months or less, when purchased, to be cash equivalents. There were no cash equivalents as of December 31, 2016 and 2015. The Company maintains its cash balances at one financial institution that is insured by the Federal Deposit Insurance Corporation. Accounts Receivable Accounts receivable consists of invoicedand unpaid product sales. The Company records an allowance for doubtful accounts to allow for any amounts that may not be recoverable, which is based on an analysis of the Companys prior collection experience, customer credit worthiness, and current economic trends. During the years ended December 31, 2016 and 2015, we recorded no allowances for doubtful accounts based upon managements review of accounts receivable. On October 4, 2016, the Company executed a non-recourse receivables financing agreement with Citibank whereby receivables due to the Company are assumed from Wal-Mart Stores Inc. by Citibank and paid to the Company in a shorter period than otherwise provided for in accordance with the Companys Supplier Agreement with Wal-Mart Stores Inc., subject to a fixed interest premium based upon LIBOR. Prepaid Expenses The Company considers all items incurred for future services to be prepaid expenses. As of December 31, 2016, and 2015, the Company had prepaid expenses of $639 and $1,282, respectively, comprised of the issuance of unregistered shares of the Companys common stock to consultants. Recoverability of Long-Lived Assets The Company reviews its long-lived assets on a periodic basis, namely intellectual property, whenever events and changes in circumstances have occurred which may indicate a possible impairment. The assessment for potential impairment will be based primarily on the Companys ability to recover the carrying value of its long-lived assets from expected future cash flows from its operations on an undiscounted basis. If such assets are determined to be impaired, the impairment recognized is the amount by which the carrying value of the assets exceeds the fair value of the assets. Fixed assets to be disposed of by sale will be carried at the lower of the then current carrying value or fair value less estimated costs to sell. The Company evaluates the carrying value of goodwill during the fourth quarter of each year and between annual evaluations if events occur or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. Such circumstances could include, but are not limited to (1) a significant adverse change in legal factors or in business climate, (2) unanticipated competition, or (3) an adverse action or assessment by a regulator. When evaluating whether goodwill is impaired, the Company compares the fair value of the reporting unit to which the goodwill is assigned to the reporting units carrying amount, including goodwill. The fair value of the reporting unit is estimated using a combination of the income, or discounted cash flows, approach and the market approach, which utilizes comparable companies data. If the carrying amount of a reporting unit exceeds its fair value, then the amount of the impairment loss must be measured. The impairment loss would be calculated by comparing the implied fair value of reporting unit goodwill to its carrying amount. In calculating the implied fair value of reporting unit goodwill, the fair value of the reporting unit is allocated to all the other assets and liabilities of that unit based on their fair values. The excess of the fair value of a reporting unit over the amount assigned to its other assets and liabilities, is the implied fair value of goodwill. We make critical assumptions and estimates in completing impairment assessments of goodwill and other intangible assets. Our cash flow projections look several years into the future and include assumptions on variables such as future sales and operating margin growth rates, economic conditions, market competition, inflation and discount rates. A 10% decrease in the estimated discounted cash flows for the reporting units tested would result in impairment that is not material to our results of operations. A 1.0 percentage point increase in the discount rate used would also result in impairment that is not material to our results of operations. We amortize the cost of other intangible assets over their estimated useful lives, which range up to ten years, unless such lives are deemed indefinite. Intangible assets with indefinite lives are tested in the third quarter of each fiscal year for impairment, or more often if indicators warrant. During the years ended December 31, 2016 and 2015, we recorded no impairment charges related to other intangible assets. Fair Value of Financial Instruments The carrying amount reported in the balance sheets for cash, accounts payable, accrued expenses, and short-term notes approximate fair value because of the immediate or short-term maturity of these financial instruments. The Company does not utilize derivative instruments. ASC 820, Fair Value Measurements and Disclosures Level 1 Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities Level 2 Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means. Level 3 Inputs that are both significant to the fair value measurement and unobservable. Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of December 31, 2016. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. Beneficial Conversion Features ASC 470-20 applies to convertible securities with beneficial conversion features that must be settled in stock and to those that give the issuer a choice in settling the obligation in either stock or cash. ASC 470-20 requires that the beneficial conversion feature should be valued at the commitment date as the difference between the conversion price and the fair market value of the common stock into which the security is convertible, multiplied by the number of shares into which the security is convertible. This amount is recorded as a debt discount and amortized over the life of the debt. ASC 470-20 further limits this amount to the proceeds allocated to the convertible instrument. Income Taxes The Company accounts for income taxes utilizing the liability method of accounting. Under the liability method, deferred taxes are determined based on differences between financial statement and tax bases of assets and liabilities at enacted tax rates in effect in years in which differences are expected to reverse. Valuation allowances are established, when necessary, to reduce deferred tax assets to amounts that are expected to be realized. The Company follows ASC 740-10, Accounting for Uncertainty in Income Taxes (ASC 740-10). This interpretation requires recognition and measurement of uncertain income tax positions using a more-likely-than-not approach. The Company has adopted ASC 740-10 for 2016, and evaluatesitstax positions on an annual basis, and as of December 31, 2016, no additional accrual for income taxes is necessary. The Companys policy is to recognize both interest and penalties related to unrecognized tax benefits expected to result in payment of cash within one year are classified as accrued liabilities, while those expected beyond one year are classified as other liabilities. The Company has not recorded any interest or penalties since its inception. The Company is required to file income tax returns in the U.S. federal tax jurisdiction and in various state tax jurisdictions and tax years 2013, 2014 and 2015 remain open for examination by federal and/or state tax jurisdictions. The Company is currently not under examination by any other tax jurisdictions for any tax year. Revenue Recognition In accordance with Securities and Exchange Commission Staff Accounting Bulletin (SAB) No. 104, Revenue Recognition , (codified in ASC 605) the Company recognizes revenue when (i) persuasive evidence of a customer or distributor arrangement exists or acceptance occurs, (ii) a retailer, distributor or wholesaler receives the goods, (iii) the price is fixed or determinable, and (iv) collectability of the sales revenues is reasonably assured. Customer Concentration The Company generates most ofits revenues from sales to a single customer, Wal-MartStores, Inc. which accounted for approximately 99% of total revenues in 2016. Share Based Compensation The Company accounts for share-based compensation in accordance with the fair value recognition provisions of the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) No. 718 and No. 505. The Company issues restricted stock to employees for their services. Cost for these transactions are measured at the fair value of the equity instruments issued at the date of grant. These shares are considered fully vested and the fair market value is recognized as expense in the period granted. The Company also issues restricted stock to consultants for various services. Costs for these transactions are measured at the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. The value of the common stock is measured at the earlier of (i) the date at which a firm commitment only if there is sufficient disincentive to ensure performance or (ii) the date at which the counterparty's performance is complete. The Company recognized consulting expenses and a corresponding increase to additional paid-in-capital related to stock issued for services. For agreements requiring future services, the consulting expense is to be recognized ratably over the requisite service period. (Loss) Per Share of Common Stock Basic net loss per common share is computed using the weighted average number of common shares outstanding. Diluted earnings per share (EPS) include additional dilution from common stock equivalents, such as stock issuable pursuant to the exercise of stock options warrants and convertible notes. Common stock equivalents are not included in the computation of diluted earnings per share when the Company reports a loss because to do so would be anti-dilutive for periods presented. Except as noted below, the Company has not issued any options or warrants to date. At December 31, 2016, the total shares issuable upon conversion of convertible notes payable would be approximately 38,182,050 shares of the Companys common stock. Inventory Inventory is stated at the lower of cost (FIFO: first-in, first-out) or market, and includes finished goods. The cost of finished goods includes the cost of packaging supplies, direct and indirect labor and other indirect manufacturing costs. As of December 31, 2016, and 2015, the Company had inventory of $0 and $8,730, respectively, with no allowance for obsolescence. Recently Issued Accounting Standards Not Yet Adopted In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in ASC 605, Revenue Recognition. This guidance is based on the principle that revenue is recognized to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This guidance also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. This guidance can be adopted either retrospectively to each prior reporting period presented, or retrospectively with a cumulative-effect adjustment recognized as of the date of adoption. The original effective date of this guidance for public entities was for annual reporting periods beginning after December 15, 2016. In August 2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers (Topic 606), to defer the effective date of this guidance by one year, to the annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. A reporting entity may choose to early adopt the guidance as of the original effective date. We do not anticipate early adoption, and are currently evaluating the impact on our financial statements upon the adoption of this guidance. |
STOCKHOLDERS' DEFICIT
STOCKHOLDERS' DEFICIT | 12 Months Ended |
Dec. 31, 2016 | |
Notes to Financial Statements | |
NOTE 3 - STOCKHOLDERS' DEFICIT | Our current authorized common shares are 200,000,000 and 1000 preferred voting shares. As of December 31, 2016, 3,312,273 of the Companys common stock and 1,000 shares of the Companys preferred stock were issued and outstanding. Issuances pursuant to conversions During January 2015, the Company issued 58,092 shares of common stock to a corporation for conversion of $250 principal and $40 accrued interest related to a Note. These shares were valued at $0.005 per share, the conversion price as stated in the Note. During February 2015, the Company issued 177,072 shares of common stock to a corporation for conversion of $886 in principal and accrued interest related to a Note. These shares were valued at $0.005 per share, the conversion price as stated in the Note. During March 2015, the Company issued 162,264 shares of common stock to a corporation for conversion of $541 in principal and accrued interest related to a Note. These shares were valued at $0.005 per share, the conversion price as stated in the Note. During April 2015, the Company issued 86,882 shares of common stock to a corporation for conversion of $400 principal and $40 accrued interest related to Note. These shares were valued at $0.005 per share, the conversion price as stated in the Note. During June 2015, the Company issued 87,564 shares of common stock to a corporation for conversion of $400 principal and $38 accrued interest related to a Note. These shares were valued at $0.005 per share, the conversion price as stated in the Note. During September 2015, the Company issued 88,438 shares of common stock to a corporation for conversion of $400 principal and $42 accrued interest related to a Note. These shares were valued at $0.005 per share, the conversion price as stated in the Note. During November 2015, the Company issued 89,020 shares of common stock to a corporation for conversion of $400 principal and $45 accrued interest related to a Note. These shares were valued at $0.004 per share, the conversion price stated in the Note. During December 2015, the Company issued 111,864 shares of common stock to a corporation for conversion of $500 principal and $59 accrued interest related to a Note. These shares were valued at $0.07 per share, the conversion price stated in the Note. During February 2016, the Company issued 90,094 unregistered shares of common stock to a corporation for conversion of $400 principal and $51 accrued interest related to a Note. These unregistered shares were valued at $0.005 per share, the fixed conversion price stated in the Note. During June 2016, the Company issued 130,000 unregistered shares of common stock to a corporation for conversion of $845 of accrued interest related to a Note. These unregistered shares were valued at $0.0065 per share, the fixed conversion price stated in the Note. During June 2016, the Company issued 81,250 unregistered shares of common stock to a corporation for conversion of $650 accrued interest related to a Note. These unregistered shares were valued at $0.008 per share, the fixed conversion price stated in the Note. During August 2016, the Company issued 129,358 unregistered shares of common stock to a corporation for conversion of $1000 principal and $35 accrued interest related to a Note. These unregistered shares were valued at $0.008 per share, the conversion price stated in the Note. During September 2016, the Company issued 121,483 unregistered shares of common stock to a corporation for conversion of $950 principal and $22 accrued interest related to a Note. These unregistered shares were valued at $0.008 per share, the fixed conversion price stated in the Note. During October 2016, the Company issued 134,881 unregistered shares of common stock to a corporation for conversion of $1,050 principal and $29 accrued interest related to a Note. These unregistered shares were valued at $0.008 per share, the fixed conversion price stated in the Note. During November 2016, the Company issued 148,319 unregistered shares of common stock to a corporation for conversion of $1,150 principal and $37 accrued interest related to a Note. These unregistered shares were valued at $0.008 per share, the fixed conversion price stated in the Note. Issuances pursuant to agreements During February 2015, the Company issued 70,867 unregistered shares of the Companys common stock as compensation to the Companys chairman of the board. The shares were valued at $0.08467 per share or $6,000. During April 2015, the Company issued 50,000 unregistered shares of the Companys common stock in final settlement of a consulting agreement. The shares were valued at $1,787. During May 2015, the Company issued 100,000 unregistered shares of the Companys common stock in final settlement of an outstanding debt. The shares were valued at $22,775. During June 2015, the Company issued 10,000 unregistered shares of the Companys common stock as compensation to a consultant. The shares were valued at $500. During November 2015, the Companys issued 50,000 unregistered shares of the Companys common stock as compensation to a consultant. These shares were valued at $0.07 per share or $3,500. During July 2016, the Company issued 25,000 unregistered shares of the Companys common stock as compensation. The shares were valued at $1,875. |
NOTES PAYABLE
NOTES PAYABLE | 12 Months Ended |
Dec. 31, 2016 | |
Notes to Financial Statements | |
NOTE 4 - NOTES PAYABLE | Notes payable, related party: On May 1, 2016, the Company issued a $35,000 note to a corporation owned by the Companys CEO. The loan bears interest at 24% per annum and has a maturity date of December 31, 2016. $35,000 remains outstanding as of December 31, 2016. On March 11, 2016, the Company issued a $35,000 note to a corporation owned by the Company's CEO. The loan bears interest at 24% per annum and has a maturity date of July 11, 2016. On July 29, 2016, the loan was repaid in full. Notes payable: On September 15, 2016, the Company issued a $5,000 note to a corporation. The loan bears interest at 12% per annum and is payable on demand. $5,000 remains outstanding at December 31, 2016. On May 18, 2016, the Company issued a $30,000 note to a corporation. The loan bears interest at 24% per annum and has a maturity date of July 18, 2016. On July 21, 2016, the loan was repaid in full. Convertible notes payable, related party The Company consolidated 18 separate convertible promissory notes of various principal amounts and fixed conversion prices, all bearing 5% interest per annum, issued to a corporation owned by the Companys CEO during the period from August 4, 2014 through April 1, 2016, into a single convertible promissory note of $112,157, bearing 5% interest per annum with a pro-rata fixed conversion price of $0.011, plus $5,939 accrued interest not subject to additional interest. The consolidation was for the purposes of administrative simplification and no inducement nor benefit was given to the corporation owned by the Companys CEO. The current net note balance is $112,157. Convertible notes payable: The Company consolidated 20 separate convertible promissory notes of various principal amounts and fixed conversion prices, all bearing 5% interest per annum, issued to corporation during the period from August 2, 2013 through April 1, 2016, into a single convertible promissory note of $169,065, bearing 5% interest per annum with a pro-rata fixed conversion price of $0.008, plus $12,516 accrued interest not subject to additional interest. The consolidation was for the purposes of administrative simplification and no inducement nor benefit was given to the corporation. The current net note balance is $164,670. On December 10, 2013, the Company issued a convertible note to an individual. The loan bears interest at 5% per annum, has a fixed conversion price of $0.015 and a maturity date of June 10, 2014. $3,000 remains outstanding at December 31, 2016. Other notes payable: On December 10, 2013, the Company issued a convertible note to an individual. The loan bears interest at 5% per annum, has a fixed conversion price of $0.015 and a maturity date of June 10, 2014. $5,000 remains outstanding at December 31, 2016. On June 11, 2013, the Company issued three convertible notes to three corporations. The loans bear interest at 5% per annum with fixed conversion prices of $0.0065 and maturity dates of August 11, 2013. $18,377 remains outstanding at December 31, 2016. On January 25, 2013, the Company issued a $12,000 note to an individual. $6,000 remains outstanding at December 31, 2016. On April 20, 2012, the Company issued a convertible note to an individual. The loan bears interest at 5% per annum, has a fixed conversion price of $0.009 and a maturity date of October 20, 2012. $2,500 remains outstanding at December 31, 2016. At December 31, 2016, accrued interest on all notes and convertible notes amounted to $38,631. |
PROVISION FOR INCOME TAXES
PROVISION FOR INCOME TAXES | 12 Months Ended |
Dec. 31, 2016 | |
Notes to Financial Statements | |
NOTE 5 - PROVISION FOR INCOME TAXES | Deferred income taxes are determined using the liability method for the temporary differences between the financial reporting basis and income tax basis of the Companys assets and liabilities. Deferred income taxes are measured based on the tax rates expected to be in effect when the temporary differences are included in the Companys tax return. Deferred tax assets and liabilities are recognized based on anticipated future tax consequences attributable to differences between financial statement carrying amounts of assets and liabilities and their respective tax bases. The income tax provision (benefit) consists of the following: December 31, 2016 2015 Federal Current $ - $ - Deferred (2,060,384) (1,926,274 ) State and local Current Deferred (2,060,384 ) (1,926,274 ) Change in valuation allowance 2,060,384 1,926,274 Income tax provision (benefit) $ - $ - At December 31, 2016 and 2015, the Company had a net operating loss (NOLs) carry forward in the amount of $6,243,587 and $5,837,194, respectively, available to offset future taxable income. The Company established valuation allowances equal to the full amount of the deferred tax assets due to the uncertainty of the utilization of the operating losses in future periods. The Company has not filed its federal tax returns from inception through fiscal 2013 and therefore, the NOLs will not be available to offset future taxable income until the outstanding tax returns are filed with the respective federal tax authorities. A reconciliation of the Companys effective tax rate as a percentage of income before taxes and federal statutory rate for the periods ended December 31, 2016 and 2015 is summarized below. 2016 2015 Federal statutory rate (34.0 )% (34.0 )% State income taxes, net of federal benefits 0.0 0.0 Valuation allowance 34.0 34.0 |
INTELLECTUAL PROPERTY
INTELLECTUAL PROPERTY | 12 Months Ended |
Dec. 31, 2016 | |
Notes to Financial Statements | |
NOTE 6 - INTELLECTUAL PROPERTY | On October 1, 2014, the Company entered into an Intellectual Property Purchase Agreement to purchase the Glucose Health Natural Blood Sugar Maintenance product for the purchase price of 300,000 unregistered shares of the Companys common stock from a company beneficially owned by the Companys CEO, Murray Fleming.The shares were recorded at their par value of $0.001per share or $300, valued at the nominal historical cost of the related party seller. All assets other than the intellectual property had a fair value of $0, with the intellectual property valued at $240 net of $60 of accumulated amortization. |
COMMITMENTS_CONTINGENCIES
COMMITMENTS/CONTINGENCIES | 12 Months Ended |
Dec. 31, 2016 | |
Notes to Financial Statements | |
NOTE 7 - COMMITMENTS/CONTINGENCIES | From time to time, we may be involved in litigation in the ordinary course of business. We are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations. Operating Agreements On January 8, 2016, we signed a Supplier Agreement with Wal-Mart Stores Inc. of Bentonville AR. On January 25, 2016, we signed a Contract Manufacturing Agreement with Natural Solution Labs of Gravette, AR. On February 3, 2016, we signed a Product Liability Insurance Agreement with Western Heritage Insurance. On April 12, 2016, we signed a Warehousing/Logistics agreement with RR/NWA Logistics of Rogers, AR. |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 12 Months Ended |
Dec. 31, 2016 | |
Notes to Financial Statements | |
NOTE 8 - SUBSEQUENT EVENTS | None. |
SUMMARY OF SIGNIFICANT ACCOUN15
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 12 Months Ended |
Dec. 31, 2016 | |
Summary Of Significant Accounting Policies Policies | |
Use of Estimates | The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to revenue recognition, bad debts, investments, intangible assets, and income taxes. Our estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may differ from these estimates. |
Comprehensive Income (Loss) | The Company adopted ASC 220-10, Reporting Comprehensive Income. ASC 220-10 requires the reporting of comprehensive income in addition to net income from operations.Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of information that historically has not been recognized in the calculation of net income. |
Cash Flow Reporting | The Company follows ASC 230, Statement of Cash Flows, for cash flow reporting, classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (indirect method) as defined by ASC 230, Statement of Cash Flows, to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments. |
Cash and Cash Equivalents | The Company considers all highly liquid debt instruments and other short-term investments with maturity of three months or less, when purchased, to be cash equivalents. There were no cash equivalents as of December 31, 2016 and 2015. The Company maintains its cash balances at one financial institution that is insured by the Federal Deposit Insurance Corporation. |
Accounts Receivable | Accounts receivable consists of invoicedand unpaid product sales. The Company records an allowance for doubtful accounts to allow for any amounts that may not be recoverable, which is based on an analysis of the Companys prior collection experience, customer credit worthiness, and current economic trends. During the years ended December 31, 2016 and 2015, we recorded no allowances for doubtful accounts based upon managements review of accounts receivable. On October 4, 2016, the Company executed a non-recourse receivables financing agreement with Citibank whereby receivables due to the Company are assumed from Wal-Mart Stores Inc. by Citibank and paid to the Company in a shorter period than otherwise provided for in accordance with the Companys Supplier Agreement with Wal-Mart Stores Inc., subject to a fixed interest premium based upon LIBOR. |
Prepaid Expenses | The Company considers all items incurred for future services to be prepaid expenses. As of December 31, 2016, and 2015, the Company had prepaid expenses of $639 and $1,282, respectively, comprised of the issuance of unregistered shares of the Companys common stock to consultants. |
Recoverability of Long-Lived Assets | The Company reviews its long-lived assets on a periodic basis, namely intellectual property, whenever events and changes in circumstances have occurred which may indicate a possible impairment. The assessment for potential impairment will be based primarily on the Companys ability to recover the carrying value of its long-lived assets from expected future cash flows from its operations on an undiscounted basis. If such assets are determined to be impaired, the impairment recognized is the amount by which the carrying value of the assets exceeds the fair value of the assets. Fixed assets to be disposed of by sale will be carried at the lower of the then current carrying value or fair value less estimated costs to sell. The Company evaluates the carrying value of goodwill during the fourth quarter of each year and between annual evaluations if events occur or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. Such circumstances could include, but are not limited to (1) a significant adverse change in legal factors or in business climate, (2) unanticipated competition, or (3) an adverse action or assessment by a regulator. When evaluating whether goodwill is impaired, the Company compares the fair value of the reporting unit to which the goodwill is assigned to the reporting units carrying amount, including goodwill. The fair value of the reporting unit is estimated using a combination of the income, or discounted cash flows, approach and the market approach, which utilizes comparable companies data. If the carrying amount of a reporting unit exceeds its fair value, then the amount of the impairment loss must be measured. The impairment loss would be calculated by comparing the implied fair value of reporting unit goodwill to its carrying amount. In calculating the implied fair value of reporting unit goodwill, the fair value of the reporting unit is allocated to all the other assets and liabilities of that unit based on their fair values. The excess of the fair value of a reporting unit over the amount assigned to its other assets and liabilities, is the implied fair value of goodwill. We make critical assumptions and estimates in completing impairment assessments of goodwill and other intangible assets. Our cash flow projections look several years into the future and include assumptions on variables such as future sales and operating margin growth rates, economic conditions, market competition, inflation and discount rates. A 10% decrease in the estimated discounted cash flows for the reporting units tested would result in impairment that is not material to our results of operations. A 1.0 percentage point increase in the discount rate used would also result in impairment that is not material to our results of operations. We amortize the cost of other intangible assets over their estimated useful lives, which range up to ten years, unless such lives are deemed indefinite. Intangible assets with indefinite lives are tested in the third quarter of each fiscal year for impairment, or more often if indicators warrant. During the years ended December 31, 2016 and 2015, we recorded no impairment charges related to other intangible assets. |
Fair Value of Financial Instruments | The carrying amount reported in the balance sheets for cash, accounts payable, accrued expenses, and short-term notes approximate fair value because of the immediate or short-term maturity of these financial instruments. The Company does not utilize derivative instruments. ASC 820, Fair Value Measurements and Disclosures Level 1 Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities Level 2 Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means. Level 3 Inputs that are both significant to the fair value measurement and unobservable. Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management as of December 31, 2016. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. |
Beneficial Conversion Features | ASC 470-20 applies to convertible securities with beneficial conversion features that must be settled in stock and to those that give the issuer a choice in settling the obligation in either stock or cash. ASC 470-20 requires that the beneficial conversion feature should be valued at the commitment date as the difference between the conversion price and the fair market value of the common stock into which the security is convertible, multiplied by the number of shares into which the security is convertible. This amount is recorded as a debt discount and amortized over the life of the debt. ASC 470-20 further limits this amount to the proceeds allocated to the convertible instrument. |
Income Taxes | The Company accounts for income taxes utilizing the liability method of accounting. Under the liability method, deferred taxes are determined based on differences between financial statement and tax bases of assets and liabilities at enacted tax rates in effect in years in which differences are expected to reverse. Valuation allowances are established, when necessary, to reduce deferred tax assets to amounts that are expected to be realized. The Company follows ASC 740-10, Accounting for Uncertainty in Income Taxes (ASC 740-10). This interpretation requires recognition and measurement of uncertain income tax positions using a more-likely-than-not approach. The Company has adopted ASC 740-10 for 2016, and evaluatesitstax positions on an annual basis, and as of December 31, 2016, no additional accrual for income taxes is necessary. The Companys policy is to recognize both interest and penalties related to unrecognized tax benefits expected to result in payment of cash within one year are classified as accrued liabilities, while those expected beyond one year are classified as other liabilities. The Company has not recorded any interest or penalties since its inception. The Company is required to file income tax returns in the U.S. federal tax jurisdiction and in various state tax jurisdictions and tax years 2013, 2014 and 2015 remain open for examination by federal and/or state tax jurisdictions. The Company is currently not under examination by any other tax jurisdictions for any tax year. |
Revenue Recognition | In accordance with Securities and Exchange Commission Staff Accounting Bulletin (SAB) No. 104, Revenue Recognition , (codified in ASC 605) the Company recognizes revenue when (i) persuasive evidence of a customer or distributor arrangement exists or acceptance occurs, (ii) a retailer, distributor or wholesaler receives the goods, (iii) the price is fixed or determinable, and (iv) collectability of the sales revenues is reasonably assured. |
Customer Concentration | The Company generates most ofits revenues from sales to a single customer, Wal-MartStores, Inc. which accounted for approximately 99% of total revenues in 2016. |
Share Based Compensation | The Company accounts for share-based compensation in accordance with the fair value recognition provisions of the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) No. 718 and No. 505. The Company issues restricted stock to employees for their services. Cost for these transactions are measured at the fair value of the equity instruments issued at the date of grant. These shares are considered fully vested and the fair market value is recognized as expense in the period granted. The Company also issues restricted stock to consultants for various services. Costs for these transactions are measured at the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. The value of the common stock is measured at the earlier of (i) the date at which a firm commitment only if there is sufficient disincentive to ensure performance or (ii) the date at which the counterparty's performance is complete. The Company recognized consulting expenses and a corresponding increase to additional paid-in-capital related to stock issued for services. For agreements requiring future services, the consulting expense is to be recognized ratably over the requisite service period. |
(Loss) per share of common stock | Basic net loss per common share is computed using the weighted average number of common shares outstanding. Diluted earnings per share (EPS) include additional dilution from common stock equivalents, such as stock issuable pursuant to the exercise of stock options warrants and convertible notes. Common stock equivalents are not included in the computation of diluted earnings per share when the Company reports a loss because to do so would be anti-dilutive for periods presented. Except as noted below, the Company has not issued any options or warrants to date. At December 31, 2016, the total shares issuable upon conversion of convertible notes payable would be approximately 38,182,050 shares of the Companys common stock. |
Inventory | Inventory is stated at the lower of cost (FIFO: first-in, first-out) or market, and includes finished goods. The cost of finished goods includes the cost of packaging supplies, direct and indirect labor and other indirect manufacturing costs. As of December 31, 2016, and 2015, the Company had inventory of $0 and $8,730, respectively, with no allowance for obsolescence. |
Recent Issued Accounting Standards | In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in ASC 605, Revenue Recognition. This guidance is based on the principle that revenue is recognized to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This guidance also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. This guidance can be adopted either retrospectively to each prior reporting period presented, or retrospectively with a cumulative-effect adjustment recognized as of the date of adoption. The original effective date of this guidance for public entities was for annual reporting periods beginning after December 15, 2016. In August 2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers (Topic 606), to defer the effective date of this guidance by one year, to the annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. A reporting entity may choose to early adopt the guidance as of the original effective date. We do not anticipate early adoption, and are currently evaluating the impact on our financial statements upon the adoption of this guidance. |
PROVISION FOR INCOME TAXES (Tab
PROVISION FOR INCOME TAXES (Tables) | 12 Months Ended |
Dec. 31, 2016 | |
Provision For Income Taxes Tables | |
PROVISION FOR INCOME TAXES | December 31, 2016 2015 Federal Current $ - $ - Deferred (2,060,384) (1,926,274 ) State and local Current Deferred (2,060,384 ) (1,926,274 ) Change in valuation allowance 2,060,384 1,926,274 Income tax provision (benefit) $ - $ - |
Reconciliation of the Companys effective tax rate | 2016 2015 Federal statutory rate (34.0 )% (34.0 )% State income taxes, net of federal benefits 0.0 0.0 Valuation allowance 34.0 34.0 |
ORGANIZATION AND BASIS OF PRE17
ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative) - USD ($) | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Organization And Basis Of Presentation Details Narrative | ||
State of incorporation | Nevada | |
Date of incorporation | Mar. 27, 2007 | |
Common stock, shares authorized | 200,000,000 | 200,000,000 |
Preferred voting shares | 1,000 | |
Common stock, shares issued | 3,312,273 | 2,451,888 |
Preferred stock, shares issued | 1,000 | 1,000 |
Working capital deficit | $ 495,687 | |
Accumulated deficit | (6,247,637) | $ (5,837,194) |
Additional capital needed, estimate | $ 120,000 |
SUMMARY OF SIGNIFICANT ACCOUN18
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($) | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Summary Of Significant Accounting Policies Details Narrative | ||
Prepaid expenses | $ 639 | $ 1,282 |
Conversion of convertible notes | 38,182,050 | 2,327,352 |
Inventory | $ 8,370 | |
Decrease estimated discounted cash flows | 10.00% | |
Increase estimated discount rate | 1.00% | |
Estimated useful lives, intagible assets | 10 years | |
Percentage of revenues, one customer | 99.00% |
STOCKHOLDERS' DEFICIT (Details
STOCKHOLDERS' DEFICIT (Details Narrative) - USD ($) | 1 Months Ended | |||||||||||||||||
Nov. 30, 2016 | Oct. 31, 2016 | Sep. 30, 2016 | Aug. 31, 2016 | Jul. 31, 2016 | Jun. 30, 2016 | Apr. 30, 2016 | Feb. 29, 2016 | Dec. 31, 2015 | Nov. 30, 2015 | Sep. 30, 2015 | Jun. 30, 2015 | May 31, 2015 | Apr. 30, 2015 | Mar. 31, 2015 | Feb. 28, 2015 | Jan. 31, 2015 | Dec. 31, 2016 | |
Common stock, shares issued | 2,451,888 | 3,312,273 | ||||||||||||||||
Common stock, shares outstanding | 2,451,888 | 3,312,273 | ||||||||||||||||
Common stock, shares authorized | 200,000,000 | 200,000,000 | ||||||||||||||||
Preferred voting shares | 1,000 | |||||||||||||||||
Preferred stock, shares issued | 1,000 | 1,000 | ||||||||||||||||
Preferred stock, shares outstanding | 1,000 | 1,000 | ||||||||||||||||
Accrued interest | $ 6,075 | $ 5,000 | ||||||||||||||||
Issuances pursuant to conversions [Member] | ||||||||||||||||||
Common stock, shares | 111,864 | 89,020 | 88,438 | 87,564 | 86,882 | 162,264 | 177,072 | 58,092 | ||||||||||
Principal and accrued interest | $ 541 | $ 886 | ||||||||||||||||
Principal amount | $ 500 | $ 400 | $ 400 | $ 400 | $ 400 | $ 250 | ||||||||||||
Accrued interest | $ 59 | $ 45 | $ 42 | $ 38 | $ 40 | $ 40 | ||||||||||||
Stock price per share | $ 0.07 | $ 0.004 | $ 0.005 | $ 0.005 | $ 0.005 | $ 0.005 | $ 0.005 | $ 0.005 | ||||||||||
Issuances pursuant to conversions [Member] | Unregistered [Member] | ||||||||||||||||||
Common stock, shares | 148,319 | 134,881 | 121,483 | 129,358 | 130,000 | 90,094 | ||||||||||||
Principal and accrued interest | $ 845 | |||||||||||||||||
Principal amount | $ 1,150 | $ 1,050 | $ 950 | $ 1,000 | $ 400 | |||||||||||||
Accrued interest | $ 37 | $ 29 | $ 22 | $ 35 | $ 51 | |||||||||||||
Stock price per share | $ 0.008 | $ 0.008 | $ 0.008 | $ 0.008 | $ 0.0065 | $ 0.005 | ||||||||||||
Issuances pursuant to conversions one [Member] | Unregistered [Member] | ||||||||||||||||||
Common stock, shares | 81,250 | |||||||||||||||||
Principal and accrued interest | $ 650 | |||||||||||||||||
Stock price per share | $ 0.008 | |||||||||||||||||
Issuances pursuant to agreements [Member] | Unregistered [Member] | ||||||||||||||||||
Common stock, shares | 25,000 | 50,000 | 50,000 | 10,000 | 100,000 | 70,867 | ||||||||||||
Common stock, value | $ 1,875 | $ 1,787 | $ 3,500 | $ 500 | $ 22,775 | $ 6,000 | ||||||||||||
Stock price per share | $ 0.07 | $ 0.08467 |
NOTES PAYABLE (Details Narrativ
NOTES PAYABLE (Details Narrative) | 12 Months Ended |
Dec. 31, 2016USD ($)Number$ / shares | |
Accrued interest and convertible notes | $ 38,631 |
May 1, 2016 [Member] | |
Notes | $ 35,000 |
Interest rate | 24.00% |
Maturity date | Dec. 31, 2016 |
Outstanding balance | $ 35,000 |
March 11, 2016 [Member] | |
Notes | $ 35,000 |
Interest rate | 24.00% |
Maturity date | Jul. 11, 2016 |
September 15, 2016 [Member] | |
Notes | $ 5,000 |
Interest rate | 12.00% |
Outstanding balance | $ 5,000 |
May 18, 2016 [Member] | |
Notes | $ 30,000 |
Interest rate | 24.00% |
Maturity date | Jul. 18, 2016 |
Convertible notes payable, related party [Member] | |
Interest rate | 5.00% |
Outstanding balance | $ 112,157 |
Number of promissory notes | Number | 18 |
August 4, 2014 through April 1, 2016 [Member] | |
Interest rate | 5.00% |
Conversion price | $ / shares | $ 0.011 |
Accrued interest | $ 5,939 |
Convertible notes payable [Member] | |
Interest rate | 5.00% |
Outstanding balance | $ 164,670 |
Number of promissory notes | Number | 20 |
August 2, 2013 through April 1, 2016 [Member] | |
Notes | $ 169,065 |
Interest rate | 5.00% |
Conversion price | $ / shares | $ 0.008 |
Accrued interest | $ 12,516 |
December 10, 2013 [Member] | Convertible notes payable [Member] | |
Interest rate | 5.00% |
Maturity date | Jun. 10, 2014 |
Outstanding balance | $ 3,000 |
Conversion price | $ / shares | $ 0.015 |
December 10, 2013 [Member] | Other notes payable [Member] | |
Interest rate | 5.00% |
Maturity date | Jun. 10, 2014 |
Outstanding balance | $ 5,000 |
Conversion price | $ / shares | $ 0.015 |
June 11, 2013 [Member] | Other notes payable [Member] | |
Interest rate | 5.00% |
Maturity date | Aug. 11, 2013 |
Outstanding balance | $ 18,377 |
Number of promissory notes | Number | 3 |
Conversion price | $ / shares | $ 0.0065 |
January 25, 2013 [Member] | Other notes payable [Member] | |
Notes | $ 12,000 |
Outstanding balance | $ 6,000 |
April 20, 2012 [Member] | Other notes payable [Member] | |
Interest rate | 5.00% |
Maturity date | Oct. 20, 2012 |
Outstanding balance | $ 2,500 |
Conversion price | $ / shares | $ 0.009 |
PROVISION FOR INCOME TAXES (Det
PROVISION FOR INCOME TAXES (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Federal | ||
Current | ||
Deferred | (2,060,384) | (1,926,274) |
State and local | ||
Current | ||
Deferred | (2,060,384) | (1,926,274) |
Change in valuation allowance | 2,060,384 | 1,926,274 |
Income tax provision (benefit) |
PROVISION FOR INCOME TAXES (D22
PROVISION FOR INCOME TAXES (Details 1) | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Provision For Income Taxes Details 1 | ||
Federal statutory rate | (34.00%) | (34.00%) |
State income taxes, net of federal benefits | 0.00% | 0.00% |
Valuation allowance | 34.00% | 34.00% |
PROVISION FOR INCOME TAXES (D23
PROVISION FOR INCOME TAXES (Details Narrative) - USD ($) | Dec. 31, 2016 | Dec. 31, 2015 |
Provision For Income Taxes Details Narrative | ||
Net operating loss carry forward | $ 6,243,587 | $ 5,837,194 |
INTELLECTUAL PROPERTY (Details
INTELLECTUAL PROPERTY (Details Narrative) - USD ($) | Dec. 31, 2016 | Dec. 31, 2015 |
Common stock, par value | $ 0.001 | $ 0.001 |
October 1, 2014 [Member] | ||
Common stock unregistered shares | 300,000 | |
Common stock, par value | $ 0.001 | |
Historical cost | $ 300 | |
Fair value | 0 | |
Intellectual property value | 240 | |
Accumulated amortization | $ 60 |